Loading organizations...

§ Private Profile · Jakarta, Jakarta Raya, Indonesia
Digital financing platform for used car dealers in Indonesia, providing business solutions like inventory financing, buyback, leasing, and consignment.
Broom is a digital financing and business solutions platform for used car dealerships based in Jakarta, Indonesia. The company provides short-term funding by allowing auto dealers to use their car inventories as collateral, alongside offering buyback programs, leasing facilitation, and consignment sales through its proprietary application. Operating across the Indonesian market, the platform currently serves a network of over 5,000 dealer customers and generates an estimated annual revenue between $10 million and $25 million. Broom has raised a total of $48.42 million in capital, supported by prominent institutional investors including Openspace Ventures, MUFG Innovation Partners, BRI Ventures, and Quona Capital. This capital includes a recent $25 million Series A extension aimed at expanding its showroom ecosystem and accelerating inventory turnover for its clients. The company was founded in 2021 by Pandu Adi Laras and Andreas Sutanto.
Broom has raised $38.0M across 3 funding rounds.
Broom has raised $38.0M in total across 3 funding rounds.
Broom has raised $38.0M across 3 funding rounds. Most recently, it raised $25.0M Series A in September 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2024 | $25M Series A | — | AC Ventures, Openspace Ventures | Announced |
| Mar 1, 2023 | $10M Seed | Openspace Ventures | AC Ventures, BRI Ventures, Nobutake Suzuki, Quona Capital | Announced |
| Feb 1, 2022 | $3M Seed | AC Ventures | Openspace Ventures, Quona Capital | Announced |
# High-Level Overview
The search results reveal multiple entities operating under "Broom" or similar names in the technology space, making a unified assessment challenging. The most prominent is Broomx Technologies, which builds immersive virtual reality solutions for healthcare applications[1]. The company serves hospitals, healthcare providers, and mental health organizations, addressing clinical needs in pain management, stroke rehabilitation, autism spectrum disorder treatment, and cognitive stimulation[1].
Other entities with similar names—including a dissolved Scottish limited liability partnership (BROOM TECHNOLOGIES LLP, dissolved in 2017)[2] and an Indian private company incorporated in 2022[4][5]—appear to be separate organizations. Without clarity on which "Broom" is the subject, the analysis below focuses on Broomx Technologies, the most substantively documented entity in the results.
# Origin Story
Broomx Technologies positions itself as a scientifically validated provider of immersive solutions, with case studies demonstrating applications across multiple healthcare domains[1]. The company has established partnerships with established healthcare institutions, including collaboration with Northwell Health to integrate immersive technology into hospital care and work with the Spanish Pain Society to advance pain treatment methodologies[1]. The company emphasizes peer-reviewed research and rigorous testing as foundational to its credibility[1].
# Core Differentiators
# Role in the Broader Tech Landscape
Broomx operates within the expanding clinical VR/immersive technology sector, where healthcare systems increasingly seek non-pharmaceutical interventions for pain, cognitive rehabilitation, and mental health support. The company's emphasis on peer-reviewed validation positions it to capitalize on healthcare's growing demand for evidence-based digital therapeutics, particularly as post-pandemic conditions (long-COVID) and aging populations drive rehabilitation needs[1].
# Quick Take & Future Outlook
Broomx Technologies appears positioned to expand its institutional footprint as healthcare systems prioritize digital health solutions and non-invasive therapeutic options. The company's focus on scientific validation—rather than consumer-grade VR—differentiates it in a crowded immersive tech market and aligns with healthcare procurement requirements. Growth will likely depend on expanding clinical partnerships, regulatory approvals for specific therapeutic applications, and demonstrating measurable patient outcomes that justify adoption costs.
Broom has raised $38.0M in total across 3 funding rounds.
Broom's investors include AC Ventures, Openspace Ventures, BRI Ventures, Nobutake Suzuki, Quona Capital.